GO:0046527 glucosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046527 (glucosyltransferase activity) is a molecular function describing the transfer of a glucosyl group from an activated donor to an acceptor molecule, typically another carbohydrate or a lipid.
• Glucosyltransferase enzymes are widely distributed across bacteria, plants, and mammals, where they modify carbohydrates, lipids, and small molecules [1,6].
• Bacterial glucosyltransferases such as Clostridium difficile Toxin B rely on this activity for disease pathogenesis, making it a validated virulence target.
• In mammals, UDP-glucose ceramide glucosyltransferase (UGCG) uses glucosyltransferase activity to synthesize glucosylceramide, a lipid that supports cancer cell survival.
• Small-molecule inhibitors of glucosyltransferase activity, such as isofloridoside, can block Streptococcus mutans biofilm formation.
• CRISPR-based knockout, point-mutation, and knock-in models are powerful tools to dissect the causal roles of glucosyltransferase genes in infection, cancer, and metabolism [2,5].
Description
Glucosyltransferase activity (GO:0046527) is a fundamental enzymatic function that attaches a glucose moiety to a diverse range of acceptor molecules, including carbohydrates, lipids, proteins, and small-molecule natural products [1,6]. This activity is essential for the biosynthesis of complex glycans, glycolipids, and secondary metabolites across all domains of life. In bacteria, glucosyltransferases often act as virulence factors that modify host targets or build protective extracellular matrices [2,7]. In plants, they contribute to the production of flavonoid glycosides and other specialized metabolites. In mammals, glucosyltransferase activity is required for the synthesis of glucosylceramide, a key sphingolipid involved in membrane trafficking and cell signaling. Because of its broad biological impact, glucosyltransferase activity is a focal point for researchers in microbiology, plant biology, cancer biology, and drug discovery [1,2,5,6,7]. Understanding the molecular mechanisms, key genes, and regulatory networks of glucosyltransferase activity is therefore critical for both basic science and translational applications [1,2,5].
glucosyltransferase activity At A Glance
| GO ID | GO:0046527 |
|---|---|
| GO term | glucosyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Transfer of a glucosyl group to an acceptor molecule, typically another carbohydrate or a lipid |
| Enzyme class | Glycosyltransferase (EC 2.4.1.-) |
| Common donors | UDP-glucose, ADP-glucose, GDP-glucose, sucrose |
| Representative acceptors | Carbohydrates, lipids, proteins, flavonoids, antibiotics |
| Cellular contexts | Cytosol, membrane, extracellular matrix, host-pathogen interface |
What Is GO:0046527?
According to the Gene Ontology, GO:0046527 (glucosyltransferase activity) is defined as the catalysis of the transfer of a glucosyl group to an acceptor molecule, typically another carbohydrate or a lipid. In practice, this means an enzyme binds an activated glucose donor, such as UDP-glucose, and transfers the glucose unit to a hydroxyl, amino, or thiol group on a substrate. The reaction can modify small molecules, proteins, lipids, or growing glycan chains, thereby altering their chemical properties, biological activity, or cellular localization [1,6].
Why Is glucosyltransferase activity Important in Cell Biology?
Glucosyltransferase activity is important because it controls the synthesis of essential glycoconjugates and virulence factors that influence infection, cancer progression, and metabolic health [2,5,7]. For example, the glucosyltransferase activity of Clostridium difficile Toxin B is required for disease pathogenesis, and its inhibition could reduce toxin-mediated damage. In cancer, UGCG-mediated glucosylceramide synthesis supports leukemia cell survival and resistance to venetoclax, highlighting glucosyltransferase activity as a therapeutic vulnerability. In oral microbiology, inhibiting glucosyltransferase activity with isofloridoside prevents Streptococcus mutans biofilm formation, a key step in dental caries. Thus, understanding and manipulating this activity has direct implications for drug development, microbiome engineering, and metabolic disease [2,5,7].
• Bacterial glucosyltransferases are virulence factors in pathogens such as Clostridium difficile and Legionella pneumophila [1,2].
• UGCG-mediated glucosyltransferase activity produces glucosylceramide, a lipid that promotes cancer cell survival and drug resistance.
• Plant glucosyltransferases generate flavonoid glycosides that affect color, flavor, and stress tolerance.
• Inhibition of glucosyltransferase activity can block Streptococcus mutans biofilm formation and dental caries.
• Glucosyltransferase activity is essential for the biosynthesis of complex carbohydrates in bacteria, plants, and mammals [1,6].
• Engineered CRISPR biosensors can monitor β-glucosyltransferase activity for diagnostic and screening applications.
• Cyclodextrin glucosyltransferase activity is used industrially to produce cyclodextrins for food and pharmaceutical applications.
• Glucosyltransferase activity modulates host-pathogen interactions by modifying host proteins or lipids [1,2].
• Coffee consumption may enhance post-exercise muscle glycogen recovery, a process linked to glucosyltransferase activity in glycogen synthesis.
• Targeting glucosyltransferase activity is a promising strategy for anti-virulence and anti-cancer therapies [2,5,7].
Molecular Mechanism of glucosyltransferase activity
Substrate recognition and donor binding
In simple terms: The enzyme first grabs an activated glucose donor and holds it in place.
Glucosyltransferases typically bind a nucleotide-sugar donor such as UDP-glucose or ADP-glucose in a conserved Rossmann-fold domain [1,6]. The donor binding site coordinates the glucose moiety and the phosphate groups, positioning the anomeric carbon for nucleophilic attack. In plant flavonoid glucosyltransferases, the acceptor binding pocket determines specificity for flavonoids such as flavanones. In bacterial enzymes like Legionella pneumophila SetA, the donor and acceptor sites are adapted to modify host targets.
Catalytic transfer and acceptor modification
In simple terms: The enzyme then hands the glucose to the acceptor molecule, changing its properties.
The catalytic mechanism involves nucleophilic attack by a hydroxyl or other group on the acceptor onto the anomeric carbon of the donor sugar, often assisted by a general base [1,6]. This results in the formation of a new glycosidic bond and release of the nucleotide diphosphate. For example, Clostridium difficile Toxin B uses its glucosyltransferase activity to modify Rho GTPases, disrupting host cell signaling. UGCG transfers glucose to ceramide to form glucosylceramide, a key step in sphingolipid metabolism.
Product release and enzyme turnover
In simple terms: After the reaction, the enzyme releases the modified product and can start over.
Following catalysis, the glucosylated product is released from the active site, and the enzyme undergoes conformational changes to reset for another round of catalysis [1,4]. In cyclodextrin glucosyltransferase, product specificity and disproportionation are influenced by residues such as Leu277, which affects hydrolysis and transglycosylation balance. Efficient product release is critical for high turnover and is often regulated by substrate availability and cellular localization [1,4].
Regulation by cellular environment and inhibitors
In simple terms: The enzyme's activity can be turned up or down by molecules around it.
Glucosyltransferase activity is regulated by the availability of donor and acceptor substrates, pH, and the presence of inhibitors. Isofloridoside, a novel inhibitor, blocks Streptococcus mutans glucosyltransferase activity and biofilm formation. In cancer cells, UGCG expression and activity are modulated by oncogenic signaling and metabolic stress, affecting glucosylceramide levels and drug sensitivity. These regulatory layers make glucosyltransferases attractive targets for pharmacological intervention [2,5,7].
Key Genes Involved in GO:0046527 glucosyltransferase activity
The following genes and proteins represent key glucosyltransferases and related factors that catalyze or regulate glucosyltransferase activity across bacteria, plants, and mammals.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UGCG | Synthesizes glucosylceramide from ceramide | Cancer drug resistance, sphingolipid metabolism |
| TcdB | Clostridium difficile Toxin B glucosyltransferase | Virulence and pathogenesis |
| SetA | Legionella pneumophila effector glucosyltransferase | Host-pathogen interaction |
| gtfB | Streptococcus mutans glucosyltransferase | Biofilm formation and dental caries |
| gtfC | Streptococcus mutans glucosyltransferase | Biofilm matrix synthesis |
| CGTase | Cyclodextrin glucosyltransferase | Industrial cyclodextrin production |
| UGT71G1 | Plant flavonoid glucosyltransferase | Flavonoid glycosylation |
| UGT78D2 | Plant flavonol glucosyltransferase | Secondary metabolism |
| UGT73C6 | Plant glucosyltransferase | Hormone and xenobiotic modification |
| BGT | β-glucosyltransferase | Biosensor development |
| GSK3β | Glycogen synthase kinase 3 beta | Glycogen metabolism regulation |
| GS | Glycogen synthase | Glycogen synthesis |
| GYS1 | Muscle glycogen synthase | Exercise recovery |
| GYS2 | Liver glycogen synthase | Glycogen storage |
| UGP2 | UDP-glucose pyrophosphorylase | Donor supply for glucosyltransferases |
| PGM1 | Phosphoglucomutase 1 | Glucose-1-phosphate supply |
| HK2 | Hexokinase 2 | Glucose phosphorylation |
How Is glucosyltransferase activity Regulated?
Glucosyltransferase activity is regulated at multiple levels, including substrate availability, enzyme expression, and post-translational modifications [1,5,7]. In bacteria, the expression of glucosyltransferase genes such as gtfB and gtfC is induced by sucrose and regulated by quorum-sensing pathways. In cancer cells, UGCG activity is influenced by oncogenic signaling and metabolic stress, which can alter glucosylceramide levels and affect drug sensitivity. Plant glucosyltransferases are regulated by developmental cues and environmental stresses, affecting flavonoid glycosylation. Additionally, small-molecule inhibitors like isofloridoside can directly block enzyme activity. These regulatory mechanisms provide multiple entry points for therapeutic intervention [2,5,7].
glucosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TcdB | Clostridium difficile infection | Knockout of tcdB in C. difficile; point mutations in glucosyltransferase domain |
| UGCG | Acute myeloid leukemia | UGCG knockout or overexpression in AML cell lines; venetoclax sensitivity assays |
| gtfB/gtfC | Dental caries | Streptococcus mutans knockout mutants; biofilm inhibition assays |
| SetA | Legionella pneumophila infection | SetA knockout in Legionella; host cell infection models |
| GYS1 | Exercise recovery | GYS1 knockout or knock-in in muscle cells; glycogen measurement |
Clostridium difficile infection
Clostridium difficile Toxin B requires glucosyltransferase activity to modify host Rho GTPases, leading to cytoskeletal disruption and disease pathogenesis. Inhibiting this activity could reduce toxin-mediated damage and serve as an anti-virulence strategy.
Acute myeloid leukemia
UGCG-mediated glucosyltransferase activity supports acute myeloid leukemia cell survival and resistance to venetoclax by maintaining glucosylceramide levels and endoplasmic reticulum-mitochondria communication. Targeting UGCG sensitizes leukemia cells to venetoclax, highlighting glucosyltransferase activity as a therapeutic target.
Dental caries
Streptococcus mutans glucosyltransferases synthesize glucans from sucrose, forming the biofilm matrix that contributes to dental caries. Isofloridoside inhibits glucosyltransferase activity and biofilm formation, suggesting a preventive strategy.
Metabolic and exercise physiology
Glucosyltransferase activity is involved in glycogen synthesis, and coffee consumption has been shown to increase post-exercise muscle glycogen recovery in endurance athletes, potentially through effects on glycogen synthase and related pathways.
From glucosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does UGCG glucosyltransferase activity drive venetoclax resistance? | UGCG knockout and point-mutation knock-in in AML cell lines |
| Is TcdB glucosyltransferase activity essential for C. difficile pathogenesis? | TcdB knockout and catalytic-dead point mutants in C. difficile |
| Can gtfB/gtfC knockout reduce S. mutans biofilm? | Streptococcus mutans knockout mutants |
| How does SetA glucosyltransferase modify host targets? | SetA knockout and tagged knock-in in Legionella |
| What is the role of CGTase Leu277 in product specificity? | Point mutations at Leu277 in CGTase |
| Can β-glucosyltransferase activity be monitored in real time? | CRISPR-based biosensor with engineered glucosyltransferase |
How to Study the glucosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive donor incorporation assay | Glucosyltransferase activity | Kinetic characterization and inhibitor screening |
| Fluorescent acceptor assay | Enzyme activity | High-throughput screening |
| CRISPR biosensor | β-glucosyltransferase activity | Ultrasensitive detection |
| CRISPR knockout | Gene function | Causal role in disease models [2,5] |
| Point-mutation knock-in | Catalytic residue function | Mechanistic studies |
| Biofilm inhibition assay | Glucan synthesis | Anti-virulence testing |
| Glycogen measurement | Glycogen content | Exercise physiology |
| Structural crystallography | Enzyme-substrate interactions | Rational drug design |
Enzymatic activity assays
Glucosyltransferase activity is commonly measured using radiolabeled or fluorescently labeled donor substrates, followed by chromatographic separation of products [1,6]. For example, UDP-[14C]glucose incorporation into acceptors can be quantified to determine kinetic parameters. These assays are essential for characterizing inhibitors such as isofloridoside.
CRISPR-based biosensors
A multi-modular CRISPR biomachine has been engineered for ultrasensitive monitoring of β-glucosyltransferase activity, enabling real-time detection of enzymatic activity. This approach combines CRISPR-Cas effectors with glucosyltransferase-responsive elements for diagnostic applications.
Genetic knockout and point-mutation models
CRISPR-Cas9 knockout and point-mutation knock-in models are used to dissect the causal roles of glucosyltransferase genes [2,5]. For instance, UGCG knockout in AML cells reduces glucosylceramide levels and sensitizes cells to venetoclax. Similarly, catalytic-dead mutants of TcdB abolish glucosyltransferase activity and reduce pathogenesis.
Bioinformatics and structural analysis
Sequence alignment, phylogenetic analysis, and molecular docking are used to identify conserved motifs and predict substrate specificity of glucosyltransferases [1,4,6]. Structural studies of CGTase have revealed key residues such as Leu277 that influence disproportionation and hydrolysis.
How CRISPR Can Be Used to Study GO:0046527 glucosyltransferase activity
Knockout
CRISPR-Cas9 knockout of glucosyltransferase genes such as UGCG, gtfB, or tcdB allows researchers to determine whether the enzyme is required for a specific phenotype, such as cancer cell survival or biofilm formation [2,5,7]. Knockout models provide definitive loss-of-function evidence and can be paired with rescue experiments.
Point Mutation
Point mutations in catalytic residues of glucosyltransferases, such as the glucosyltransferase domain of TcdB or Leu277 in CGTase, can abolish or alter enzyme activity without affecting protein expression [2,4]. These models are crucial for separating catalytic activity from structural roles [2,4].
Knock-in
Knock-in of tagged or mutant glucosyltransferase alleles enables precise tracking of enzyme localization and activity in live cells [1,5]. For example, tagged UGCG knock-in can reveal its subcellular distribution and interaction partners.
Overexpression
Overexpression of glucosyltransferases such as UGCG or plant UGTs can increase glucosylceramide or flavonoid glycoside levels, respectively, allowing gain-of-function studies [5,6]. Overexpression models are useful for testing whether increased activity is sufficient to drive a phenotype [5,6].
How EDITGENE Supports glucosyltransferase activity Research
Researchers studying glucosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for glucosyltransferase activity research.
Frequently Asked Questions About glucosyltransferase activity
What is glucosyltransferase activity?
Glucosyltransferase activity (GO:0046527) is the catalysis of the transfer of a glucosyl group to an acceptor molecule, typically another carbohydrate or a lipid.
What genes are involved in glucosyltransferase activity?
Key genes include UGCG in mammals, gtfB and gtfC in Streptococcus mutans, TcdB in Clostridium difficile, and plant UGTs such as UGT71G1 [2,5,6,7].
What diseases are associated with glucosyltransferase activity?
Glucosyltransferase activity is linked to Clostridium difficile infection, acute myeloid leukemia, and dental caries [2,5,7].
How is glucosyltransferase activity measured?
It is measured using radioactive or fluorescent donor incorporation assays, and more recently with CRISPR-based biosensors [1,8].
Can glucosyltransferase activity be inhibited?
Yes, small molecules such as isofloridoside inhibit Streptococcus mutans glucosyltransferase activity and biofilm formation.
What is the role of UGCG in cancer?
UGCG synthesizes glucosylceramide, which supports AML cell survival and resistance to venetoclax.
How does Clostridium difficile Toxin B use glucosyltransferase activity?
Toxin B glucosylates Rho GTPases, disrupting host cell signaling and causing disease.
What is the function of cyclodextrin glucosyltransferase?
It produces cyclodextrins from starch and is used industrially; residue Leu277 affects its product specificity.
Are there CRISPR models for glucosyltransferase research?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are available for studying glucosyltransferase genes [2,5].
How does coffee affect glycogen recovery?
Coffee consumption has been shown to increase post-exercise muscle glycogen recovery in endurance athletes, potentially involving glycogen synthase and glucosyltransferase-related pathways.
Conclusion
Glucosyltransferase activity (GO:0046527) is a versatile molecular function that underpins carbohydrate and lipid modification across bacteria, plants, and mammals [1,6]. Its roles in bacterial virulence, cancer drug resistance, and biofilm formation make it a high-value target for therapeutic intervention [2,5,7]. Advances in CRISPR-based models and biosensors are accelerating the dissection of glucosyltransferase mechanisms and the discovery of inhibitors [2,5,8]. Continued research into this activity will likely yield new strategies for treating infectious diseases, cancer, and metabolic disorders [2,5,7].
References
- 1. Levanova N et al.. 2019. Characterization of the glucosyltransferase activity of Legionella pneumophila effector SetA.. Naunyn Schmiedebergs Arch Pharmacol 392(1):69-79 PMID: 30225797
- 2. Yang Z et al.. 2015. Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis.. Gut Microbes 6(4):221-4 PMID: 26091306
- 3. Loureiro LMR et al.. 2021. Coffee Increases Post-Exercise Muscle Glycogen Recovery in Endurance Athletes: A Randomized Clinical Trial.. Nutrients 13(10) PMID: 34684336
- 4. Kong D et al.. 2021. Effect of Leu(277) on Disproportionation and Hydrolysis Activity in Bacillus stearothermophilus NO2 Cyclodextrin Glucosyltransferase.. Appl Environ Microbiol 87(12):e0315120 PMID: 33837009
- 5. Sun X et al.. 2026. Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication.. Cell Rep 45(3):117021 PMID: 41734065
- 6. Durren RL et al.. 1999. Flavanone-7-O-glucosyltransferase activity from Petunia hybrida.. Phytochemistry 52(5):793-8 PMID: 10626374
- 7. Kimijima M et al.. 2025. Isofloridoside: a novel inhibitor of Streptococcus mutans biofilm formation and glucosyltransferase activity.. BMC Res Notes 18(1):343 PMID: 40764584
- 8. Ma W et al.. 2025. Engineering of a multi-modular CRISPR biomachine for ultrasensitive monitoring of β-glucosyltransferase activity.. Biosens Bioelectron 289:117878 PMID: 40816052
